Fri, May 2, 2:31 PM (17 days ago)
**AptarGroup, Inc. (ATR) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $887.3 million, down 3% YoY due to negative currency effects. - **Operating Income:** $113.4 million, up 1.4% YoY. - **Net Income:** $78.8 million, down 5.2% YoY. - **EPS:** $1.17 (diluted), down 6.3% YoY. - **Cash Flow from Operations:** $82.7 million, down 10.4% YoY. - **Cash & Equivalents:** $125.8 million, down 43.8% from Q4 2024. **Profit Margins:** - **Operating Margin:** 12.8%, up from 12.2% in Q1 2024. - **Net Margin:** 8.9%, down from 9.1% in Q1 2024. - **Adjusted EBITDA Margin:** 20.7%, up from 19.5% in Q1 2024. **Segment Performance:** - **Aptar Pharma:** Revenue up 1% YoY, Adjusted EBITDA up 8% YoY. - **Aptar Beauty:** Revenue down 7% YoY, Adjusted EBITDA down 10% YoY. - **Aptar Closures:** Revenue down 5% YoY, Adjusted EBITDA up slightly. **Trends & Uncertainties:** - Strong volume growth in Pharma and Closures segments. - Negative currency effects impacted consolidated results. - Higher compensation costs and hosting fees increased SG&A. - Higher capital investments drove depreciation and amortization. - Restructuring initiatives continue to reduce fixed costs. **Future Operations Impact:** - Expects Q2 2025 EPS of $1.56-$1.64, excluding restructuring expenses and changes in equity investments. - Plans $280-$300 million in capital expenditures for 2025. - Strong liquidity position with $1.8 billion borrowing capacity under credit facilities. - Potential risks include economic conditions, geopolitical conflicts, and supply chain disruptions.